Assessing Non-inferiority in Treatment Trials Regarding Severe Infectious Diseases: An Extension to the Entire Follow-up Period Using a Cure-Death Multistate Model
A new publication on behalf of the COMBACTE-NET and COMBACTE-MAGNET consortiums was recently published in American Society for Microbiology‘s Antimicrobial Agents and Chemotherapy Journal. Read the full abstract below.
Background: In current and former clinical trials for the development of antibacterial drugs, various primary endpoints have been used and treatment effects are mostly evaluated in non-inferiority analyses at the end of follow-up which varies between studies. A more convincing and highly patient-relevant statement would be a non-inferiority assessment over the entire follow-up period with cure and death as co-primary endpoints, while preserving the desired alpha level for statistical testing.
Materials and Methods: To account for the time-dynamic pattern of cure and death, we apply a cure-death multistate model. The endpoint of interest is “get cured and stay alive over time”. Non-inferiority between treatments over the entire follow-up period is studied by means of one-sided confidence bands provided by a flexible resampling technique.
Results: We illustrate the technique on a recently published study and establish non-inferiority in being cured and alive over a time frame of interest for the entire population, patients with hospital-acquired pneumonia, but not for the subset of patients with ventilator-associated pneumonia. Our analysis improves the original results in the sense that our endpoint is more patient-benefiting, a stronger non-inferiority statement is demonstrated, and the time-dependency of cure and death, competing events, and different follow-up times is captured.
Summary: Multistate methodology combined with confidence bands add a valuable statistical tool for clinical trials in the context of infection control. The framework is not restricted to the cure-death model, but can be adapted to more complex multistate endpoints and equivalence or superiority analyses.
Read publication
Related media library items
Clinical presentation and antimicrobial resistance of invasive Escherichia coli disease in hospitalized older adults: a prospective multinational observational study
Background Clinical data characterizing invasive Escherichia coli disease (IED) are limited. We assessed the clinical presentation of IED and antimicr...
Feasibility of tracking invasive Escherichia coli disease among older adults in a community setting: A prospective observational study
Purpose Invasive Escherichia coli disease (IED) encompasses a diverse range of sterile site infections. This study evaluated the feasibility of captur...
Postoperative Staphylococcus aureus Infections in Patients With and Without Preoperative Colonization
Key Points Question What is the cumulative incidence of Staphylococcus aureus surgical site infections (SSIs) and bloodstream infections (BSIs) in Eu...